Apple-Cider Vinegar: Too Cheap to Be Trusted?
-
Apple-Cider Vinegar: Too Cheap to Be Trusted?
In her latest piece, Jenna McCarthy examines the irony of the BMJ retracting an ACV weight loss study, while leaving far more dangerous, pharma-backed research untouched.
Last year, a team of Lebanese researchers rounded up 120 chubby teenagers and young adults, split them into groups, and handed out daily shots of apple cider vinegar (ACV) diluted in water, while a control group got placebo lactic acid water. Twelve weeks later, the vinegar group had smaller waists, lower BMI, improved cholesterol, and better blood sugar, while the placebo group got the satisfaction of knowing they were duped into chugging knockoff kombucha for science.
The BMJ just pulled an ACV weight-loss study for “methodological issues.” Translation: Heaven forbid fermented apple juice threaten the Ozempic empire.
Meanwhile, the journal keeps rubber-stamping pharma trials that later sprout black-box warnings and billion-dollar settlements. They wave off ACV as “weak evidence,” yet we’re still waiting for the first vinegar-related organ-failure scandal.
In other words: Salad dressing = dangerous. Injectables with a recall history = totally fine. Funny how “trust the science” gets louder when there’s a patent involved.
Have you ever tried ACV (or any pocket-change remedy) and felt it got unfairly labelled “snake oil”?
Log in to reply.
